Other Viruses Citation List: January 3 - January 16, 2014
Hepatitis B Virus
1. Astershionones A-F, Six New anti-HBV Shionane-type Triterpenes from Aster tataricus. Zhou, W.B., G.Z. Zeng, H.M. Xu, W.J. He, Y.M. Zhang, and N.H. Tan. Fitoterapia, 2014. [Epub ahead of print]. PMID[24393620].
[PubMed]. OV_0103-011614.
Hepatitis C Virus
2. Anti-Hepatitis C Virus Compounds Obtained from Glycyrrhiza uralensis and Other Glycyrrhiza Species. Adianti, M., C. Aoki, M. Komoto, L. Deng, I. Shoji, T.S. Wahyuni, M.I. Lusida, Soetjipo, H. Fuchino, N. Kawahara, and H. Hotta. Microbiology and Immunology, 2014. PMID[24397541]. [PubMed]. OV_0103-011614.
3. Trinorditerpenes from the Roots of Flueggea virosa. Chao, C.H., J.C. Cheng, T.L. Hwang, D.Y. Shen, and T.S. Wu. Bioorganic & Medicinal Chemistry Letters, 2014. 24(2): p. 447-449. PMID[24388689].
[PubMed]. OV_0103-011614.
4. Anti-Hepatitis C Virus Dinorditerpenes from the Roots of Flueggea virosa. Chao, C.H., J.C. Cheng, D.Y. Shen, and T.S. Wu. Journal of Natural Products, 2014. [Epub ahead of print]. PMID[24400834].
[PubMed]. OV_0103-011614.
5. Discovery of ABT-267, a Pan-genotypic Inhibitor of HCV NS5A. Degoey, D.A., J. Randolph, D. Liu, J. Pratt, C. Hutchins, P. Donner, C. Krueger, M. Matulenko, S. Patel, C. Motter, L. Nelson, R. Keddy, M. Tufano, D. Caspi, P. Krishnan, N. Mistry, G. Koev, T. Reisch, R. Mondal, T. Pilot-Matias, G. Yi, D. Beno, C. Maring, A. Molla, E. Dumas, A. Campbell, L. Williams, C. Collins, R. Wagner, and W. Kati. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24400777].
[PubMed]. OV_0103-011614.
6. Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent C-Nucleoside monophosphate Prodrug. Feng, J.Y., G. Cheng, J. Perry, O. Barauskas, Y. Xu, M. Fenaux, S. Eng, N. Tirunagari, B. Peng, M. Yu, Y. Tian, Y.J. Lee, G. Stepan, L.L. Lagpacan, D. Jin, M. Hung, K.S. Ku, B. Han, K. Kitrinos, M. Perron, G. Birkus, K.A. Wong, W. Zhong, C.U. Kim, A. Carey, A. Cho, and A.S. Ray. Antimicrobial Agents and Chemotherapy, 2014. [Epub ahead of print]. PMID[24419349].
[PubMed]. OV_0103-011614.
7. Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, a Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase. Gentles, R.G., M. Ding, J.A. Bender, C.P. Bergstrom, K. Grant-Young, P. Hewawasam, T. Hudyma, S. Martin, A. Nickel, A. Regueiro-Ren, Y. Tu, Z. Yang, K.S. Yeung, X. Zheng, B.R. Beno, D.M. Camac, C.H. Chang, M. Gao, P.E. Morin, S. Sheriff, J. Tredup, J. Wan, M.R. Witmer, D. Xie, U. Hanumegowda, J. Knipe, K. Mosure, K.S. Santone, D.D. Parker, X. Zhuo, J. Lemm, M. Liu, L. Pelosi, K. Rigat, S. Voss, Y. Wang, Y.K. Wang, R.C. Colonno, M. Gao, S.B. Roberts, Q. Gao, A. Ng, N.A. Meanwell, and J.F. Kadow. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24397558].
[PubMed]. OV_0103-011614.
8. Nucleotide Prodrugs of 2'-Deoxy-2'-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase. Jonckers, T.H., K. Vandyck, L. Vandekerckhove, L. Hu, A. Tahri, S. Van Hoof, T.I. Lin, L. Vijgen, J.M. Berke, S. Lachau-Durand, B. Stoops, L. Leclercq, G. Fanning, B. Samuelsson, M. Nilsson, A. Rosenquist, K. Simmen, and P. Raboisson. Journal of Medicinal Chemistry, 2014. [Epub ahead of print]. PMID[24345201].
[PubMed]. OV_0103-011614.
9. UK-1 and Structural Analogs are Potent Inhibitors of Hepatitis C Virus Replication. Ward, D.N., D.C. Talley, M. Tavag, S. Menji, P. Schaughency, A. Baier, and P.J. Smith. Bioorganic & Medicinal Chemistry Letters, 2014. 24(2): p. 609-612. PMID[24360997].
[PubMed]. OV_0103-011614.
HCMV
10. DSTP-27 Prevents Entry of Human Cytomegalovirus. Paeschke, R., I. Woskobojnik, V. Makarov, M. Schmidtke, and E. Bogner. Antimicrobial Agents and Chemotherapy, 2014. [Epub ahead of print]. PMID[24419339].
[PubMed]. OV_0103-011614.
Citations from the ISI Web of Knowledge Listings for O.V.
11. Synthesis and Biological Evaluation of bis-Imidazolidineiminothiones: A Comparative Study. El-Sharief, M.A.M.S., Z. Moussa, and A.M.S. El-Sharief. Archiv der Pharmazie, 2013. 346(7): p. 542-555. ISI[000327695900006].
[WOS]. OV_0103-011614.
12. Inhibition of Hepatitis C Virus by the Cyanobacterial Protein Microcystis viridis Lectin: Mechanistic Differences between the High-mannose Specific Lectins MVL, CV-N, and GNA. Kachko, A., S. Loesgen, S. Shahzad-ul-Hussan, W. Tan, I. Zubkova, K. Takeda, F. Wells, S. Rubin, C.A. Bewley, and M.E. Major. Molecular Pharmaceutics, 2013. 10(12): p. 4590-4602. ISI[000327831500019].
[WOS]. OV_0103-011614.